Skip to content

Immunization Schedule Alert Platform

Immunization Schedule Alert Platform: Determining ISAP SMS Efficacy in Improving Childhood Immunization Timeliness and Completeness in Nigeria

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03705455
Acronym
ISAP
Enrollment
1800
Registered
2018-10-15
Start date
2018-11-01
Completion date
2019-12-31
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunization

Brief summary

The ISAP study is investigating the efficacy of SMS messages in improving routine childhood Immunization timeliness and completeness in Nigeria.

Detailed description

The ISAP - Immunization Schedule Alert Platform study is investigating the efficacy of ISAP SMS exposure to Caregivers with children( who have fulfilled our inclusion criteria) due for routine childhood Immunisation in influencing decision for timely and complete Immunization uptake. ISAP SMS messages contains information on the Immunization appointment schedule, time ,vaccine to be administered and the address of the Immunization centre.

Interventions

BEHAVIORALISAP SMS

ISAP SMS is a text message for caregivers use that provides immunization schedule and vaccine availability at the nearest immunization clinic.

Sponsors

Lifespan Healthcare Resource Limited
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Weeks to 12 Months
Healthy volunteers
Yes

Inclusion criteria

Caregiver with child due for birth dose vaccination or at 6weeks-OPV1,Penta1,PCV1,Rota1.

Exclusion criteria

Caregiver with child who have already had OPV1,Penta1,PCV1and Rota1. \-

Design outcomes

Primary

MeasureTime frameDescription
Proportion of timely and complete vaccine uptake after ISAP SMS Intervention12 monthsProportion of timely and complete vaccine uptake after ISAP SMS Intervention

Countries

Nigeria

Contacts

Primary ContactEmmanuel Ihedioha, MBBS
emmanuel.ihedioha@lifespanhcr.com23407038861841

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026